1. Home
  2. ENR vs PHAR Comparison

ENR vs PHAR Comparison

Compare ENR & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energizer Holdings Inc.

ENR

Energizer Holdings Inc.

HOLD

Current Price

$18.77

Market Cap

1.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$17.43

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENR
PHAR
Founded
2015
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ENR
PHAR
Price
$18.77
$17.43
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$24.71
$39.00
AVG Volume (30 Days)
1.1M
17.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
6.49%
N/A
EPS Growth
538.46
N/A
EPS
3.32
N/A
Revenue
$2,952,700,000.00
N/A
Revenue This Year
$4.51
$10.04
Revenue Next Year
$1.07
$2.51
P/E Ratio
$5.57
$3,041.22
Revenue Growth
2.28
N/A
52 Week Low
$16.00
$8.00
52 Week High
$30.29
$21.34

Technical Indicators

Market Signals
Indicator
ENR
PHAR
Relative Strength Index (RSI) 58.84 59.90
Support Level $16.38 $15.72
Resistance Level $21.62 $17.60
Average True Range (ATR) 0.63 0.64
MACD 0.38 0.15
Stochastic Oscillator 94.67 83.41

Price Performance

Historical Comparison
ENR
PHAR

About ENR Energizer Holdings Inc.

Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: